Piramal Pharma Faces Continued Decline Amid Broader Market Challenges

Piramal Pharma has experienced a notable decline today, with shares dropping by 3.22% as of August 1, 2025. This marks the third consecutive day of losses for the large-cap pharmaceutical company, resulting in a total decline of 7.2% over this period. The stock reached an intraday low of Rs 190.6, reflecting a decrease of 3.3% during the trading session.
In terms of moving averages, Piramal Pharma is currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. The broader Pharmaceuticals & Drugs sector has also faced challenges, with a decline of 2.9% today.

On the market front, the Sensex has continued its downward trajectory, falling by 544.51 points to settle at 80,529.90, a decrease of 0.81%. Notably, while Piramal Pharma's one-day performance is down 3.32%, the Sensex's performance reflects a smaller decline of 0.83%. Over the past month, Piramal Pharma has underperformed the Sensex, with a 6.87% drop compared to the index's 3.81% decline.